Succession
May 26, 2020 All Industries Compensation
In this episode of Looking Ahead with Blair Jones, Managing Director at Semler Brossy Consulting Group LLC, and Judy Zagorski, EVP of Global Human Resources at Church & Dwight Co., Inc, we focus on key issues specific to succession planning, its intersection with compensation, who should be involved in the process, and more.
Reevaluating Executive Compensation in the Age of Covid
May 26, 2020 All Industries Compensation
As CEOs take pay cuts to show solidarity with workers, compensation committees are turning to building bonus structures for 2021 and beyond. But the process of tying bonuses to the right metrics to incentivize management has changed under the current economic landscape.
The Post-Covid Activist Puzzle
May 26, 2020 All Industries Activism
Activist investors have a large war chest that could see them going on a spending spree, as certain stocks remain highly deflated. How boards manage the Covid-19 response could determine whether they set their sights on the company.
How Healthcare Embraced AI in Covid Fight
May 26, 2020 Healthcare Technology Trends
As hospitals faced the onslaught of scared patients fearing they had Covid-19, some organizations tip-toed into artificial intelligence to help serve as a first line of defense. The impact may send AI into the hospital mainstream.
How Retailers, Stores Hope To Rebound
May 26, 2020 All Industries Crisis Management
Many retailers faced major issues prior to the crisis, which has led to threats on their future with sales plummeting due to shelter-in-place orders. Now, as states reopen, how retailers respond could determine their survival.
Events
Transactions 2021 | Health
April 19, 2021 New York New York
Be it a strategic merger or financial acquisition, the healthcare industry has experienced record-setting deal volume over the last few years. Given transactions within the pharma and biotech space to disruptions in healthcare services, we continue to see financial sponsors seeking out new paths to grow. While some believe the pace of consolidation will increase, others wonder if pricing has become too expensive and appetites for deals, overly exuberant. So is now the time to buy, sell or go public? At DirectorCorps’ annual Transactions Conference, we explore these potential paths with top executives and members of the boards of leading healthcare organizations.